Cargando…

Clinical sepsis phenotypes in critically ill COVID-19 patients

BACKGROUND: A greater understanding of disease heterogeneity may facilitate precision medicine for coronavirus disease 2019 (COVID-19). Previous work identified four distinct clinical phenotypes associated with outcome and treatment responses in non-COVID-19 sepsis patients, but it is unknown if and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruse, Niklas, Kooistra, Emma J., Jansen, Aron, van Amstel, Rombout B. E., de Keizer, Nicolette F., Kennedy, Jason N., Seymour, Christopher, van Vught, Lonneke A., Pickkers, Peter, Kox, Matthijs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361232/ https://www.ncbi.nlm.nih.gov/pubmed/35945618 http://dx.doi.org/10.1186/s13054-022-04118-6

Ejemplares similares

Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Responses and Tolerance
por: Jansen, Aron, et al.
Publicado: (2022)

Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity
por: de Nooijer, Aline H., et al.
Publicado: (2023)

Proenkephalin Compared to Conventional Methods to Assess Kidney Function in Critically Ill Sepsis Patients
por: Beunders, Remi, et al.
Publicado: (2020)

Towards precision medicine for sepsis patients
por: Pickkers, Peter, et al.
Publicado: (2017)

Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes
por: van Amstel, Rombout B. E., et al.
Publicado: (2023)

Adrenomedullin: its double-edged sword during sepsis slices yet again
por: Kox, Matthijs, et al.
Publicado: (2014)

Precision Immunotherapy for Sepsis
por: Peters van Ton, Annemieke M., et al.
Publicado: (2018)

Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients
por: Kooistra, Emma J., et al.
Publicado: (2021)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
por: Geven, Christopher, et al.
Publicado: (2018)

The role of outcome expectancies for a training program consisting of meditation, breathing exercises, and cold exposure on the response to endotoxin administration: a proof-of-principle study
por: van Middendorp, Henriët, et al.
Publicado: (2015)

Fever in Sepsis: Still a Hot Topic
por: Leijte, Guus Pieter, et al.
Publicado: (2019)

Noradrenaline drives immunosuppression in sepsis: clinical consequences
por: Stolk, Roeland F., et al.
Publicado: (2020)

Complement activation in COVID-19 and targeted therapeutic options: A scoping review
por: Lim, Endry Hartono Taslim, et al.
Publicado: (2023)

CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo
por: Jansen, Aron, et al.
Publicado: (2023)

The value of D-dimer to predict pulmonary embolism in critically ill COVID-19 patients
por: van den Berg, M.J.W., et al.
Publicado: (2021)

Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes
por: Leijte, Guus P., et al.
Publicado: (2020)

Evidence‐based rationale for low dose nivolumab in critically ill patients with sepsis‐induced immunosuppression
por: van den Haak, Demy A. C., et al.
Publicado: (2023)

Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients
por: van Lier, Dirk, et al.
Publicado: (2021)

Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3
por: van Lier, D., et al.
Publicado: (2020)

A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients
por: Kooistra, Emma J., et al.
Publicado: (2021)

Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
por: Kooistra, Emma J., et al.
Publicado: (2020)

Gender-specific differences in outcome after trauma may be explained by differences in immunity
por: Eijk, Lucas T van, et al.
Publicado: (2014)

Commentary: Plasma angiotensin II is increased in critical coronavirus disease 2019
por: van Lier, Dirk, et al.
Publicado: (2022)

Long-Term Impairments Are Most Pronounced in Critically Ill Patients with COVID-19 with Severe Obesity
por: Kooistra, Emma, et al.
Publicado: (2022)

The leukocyte non-coding RNA landscape in critically ill patients with sepsis
por: Scicluna, Brendon P, et al.
Publicado: (2020)

Association between age and the host response in critically ill patients with sepsis
por: Michels, Erik H. A., et al.
Publicado: (2022)

Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study
por: Peters-Sengers, Hessel, et al.
Publicado: (2021)

Treatment With Acetylsalicylic Acid Reverses Endotoxin Tolerance in Humans In Vivo: A Randomized Placebo-Controlled Study
por: Leijte, Guus P., et al.
Publicado: (2019)

Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients
por: van Vught, Lonneke A., et al.
Publicado: (2016)

Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: a target trial emulation
por: Reijnders, Tom D. Y., et al.
Publicado: (2022)

Intracellular expression of granzymes A, B, K and M in blood lymphocyte subsets of critically ill patients with or without sepsis
por: García‐Laorden, M. Isabel, et al.
Publicado: (2021)

Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case series
por: van Laarhoven, Arjan, et al.
Publicado: (2021)

The host response in critically ill sepsis patients on statin therapy: a prospective observational study
por: Wiewel, Maryse A., et al.
Publicado: (2018)

Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients
por: van den Boogaard, Mark, et al.
Publicado: (2011)

THE ROLE OF OBESITY AND PLASMA ADIPOCYTOKINES IN IMMUNE DYSREGULATION IN SEPSIS PATIENTS
por: de Nooijer, Aline H., et al.
Publicado: (2023)

Pharmacokinetics, safety and tolerability of the novel β‐hCG derived immunomodulatory compound, EA‐230
por: van Groenendael, Roger, et al.
Publicado: (2019)

Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?
por: van Berkel, Miranda, et al.
Publicado: (2020)

Personalised immunotherapy in sepsis: a scoping review protocol
por: Slim, Marleen A, et al.
Publicado: (2022)

The circular RNA landscape in specific peripheral blood mononuclear cells of critically ill patients with sepsis
por: Khan, Hina N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ebn3q1aup7mebfe6jav5r26m6m